Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
H-IMYNYPAM-OH
3D-Ansicht

Biosynth logo

H-IMYNYPAM-OH

Ref. 3D-PP44770

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 27. Dezember 2024

Produktinformation

Name:
H-IMYNYPAM-OH
Synonyme:
  • NH2-Ile-Met-Tyr-Asn-Tyr-Pro-Ala-Met-OH
Beschreibung:

Peptide H-IMYNYPAM-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IMYNYPAM-OH include the following: Photochemically-Mediated Inflammation and Cross-Presentation of Mycobacterium bovis BCG Proteins Stimulates Strong CD4 and CD8 T-Cell Responses in Mice Y Waeckerle-Men, ZK Kotkowska, G Bono - Frontiers in , 2022 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2022.815609/full Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis TTKT Hoang, A Nansen, S Roy, R Billeskov - PloS one, 2009 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005928 High-frequency vaccine-induced CD8+ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection T Lindenstrom , C Aagaard - European journal of , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201344358 Rational design and in vivo characterization of vaccine adjuvants ST Schmidt, GK Pedersen , D Christensen - ILAR journal, 2018 - academic.oup.comhttps://academic.oup.com/ilarjournal/article-abstract/59/3/309/5281128 A natural polymorphism of Mycobacterium tuberculosis in the esxH gene disrupts immunodomination by the TB10.4-specific CD8 T cell response R Sutiwisesak , ND Hicks , S Boyce, KC Murphy - PLoS , 2020 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009000 Natural Polymorphism of Mycobacterium tuberculosis and CD8 T Cell Immunity R Sutiwisesak - 2020 - repository.escholarship.umassmed https://repository.escholarship.umassmed.edu/handle/20.500.14038/31300 Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen R Axelsson-Robertson, F Weichold, D Sizemore - , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2009.03201.x Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice NM Kirk, Q Huang , S Vrba , M Rahman - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1127515/full Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant KS Korsholm, J Hansen, K Karlsen, J Filskov - Vaccine, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X14007269 Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages JD Yang, D Mott, R Sutiwisesak , YJ Lu , F Raso - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1007060 Antigen Specific CD4+ and CD8+ T Cell Recognition During Mycobacterium Tuberculosis Infection JD Yang - 2018 - repository.escholarship.umassmed https://repository.escholarship.umassmed.edu/handle/20.500.14038/32354 Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology J Dietrich , S Roy, I Rosenkrands - Infection and , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.01055-15 Mycobacterium tuberculosis produces d-serine under hypoxia to limit CD8+ T cell-dependent immunity in mice H Cheng, Z Ji, Y Wang, S Li, T Tang, F Wang - Nature , 2024 - nature.comhttps://www.nature.com/articles/s41564-024-01701-1 Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis E Belnoue, A Vogelzang, NE Nieuwenhuizen - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/5/2700 Human and murine clonal CD8+ T cell expansions arise during tuberculosis because of TCR selection CN Alves, MG Booty , SM Carpenter , AC Rothchild - 2015 - repositorium.sdum.uminho.pthttps://repositorium.sdum.uminho.pt/handle/1822/40054 Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis CB Chesson, M Huante, RJ Nusbaum , AG Walker - Scientific reports, 2018 - nature.comhttps://www.nature.com/articles/s41598-018-31089-y Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis C Perdomo, U Zedler, AA Kuhl, L Lozza, P Saikali - MBio, 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/mbio.01686-16 Human and murine clonal CD8+ T cell expansions arise during tuberculosis because of TCR selection C Nunes-Alves, MG Booty , SM Carpenter - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1004849

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP44770 H-IMYNYPAM-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.